RCEL (STOCKS)
Avita Medical, Inc. Common Stock
$3.543700
-0.296300 (-7.72%)
Prev close: $3.840000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Cary Guy Vance
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $113.43M
- Employees
- 260
- P/E (TTM)
- -2.12
- P/B (TTM)
- -17.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.46 | $-0.29 | -0.1703 | -58.78% |
|
Jun 2025 (Q2)
|
$-0.38 | $-0.25 | -0.1270 | -50.20% |
|
Mar 2025 (Q1)
|
$-0.53 | $-0.39 | -0.1373 | -34.96% |
|
Dec 2024 (Q4)
|
$-0.44 | $-0.44 | +0.0018 | +0.41% |
Financial Statements
| Revenues | $72.40M |
| Benefits Costs and Expenses | $120.91M |
| Cost Of Revenue | $11.77M |
| Costs And Expenses | $120.91M |
| Gross Profit | $60.63M |
| Operating Expenses | $102.71M |
| Research and Development | $20.00M |
| Other Operating Expenses | $82.72M |
| Operating Income/Loss | -$42.08M |
| Income/Loss From Continuing Operations After Tax | -$48.56M |
| Income/Loss From Continuing Operations Before Tax | -$48.51M |
| Income Tax Expense/Benefit | $47.00K |
| Interest Expense, Operating | $5.05M |
| Net Income/Loss | -$48.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$48.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$48.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | -$27.00K |
| Basic Earnings Per Share | -$1.81 |
| Diluted Earnings Per Share | -$1.81 |
| Basic Average Shares | 27,101,057 |
| Diluted Average Shares | 27,101,057 |
| Assets | $63.73M |
| Current Assets | $41.37M |
| Cash | $23.30M |
| Inventory | $7.24M |
| Other Current Assets | $10.83M |
| Noncurrent Assets | $22.36M |
| Fixed Assets | $9.88M |
| Intangible Assets | $5.20M |
| Other Non-current Assets | $7.27M |
| Liabilities | $70.39M |
| Current Liabilities | $61.83M |
| Noncurrent Liabilities | $8.56M |
| Equity | -$6.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$6.67M |
| Liabilities And Equity | $63.73M |
| Net Cash Flow From Operating Activities | -$33.84M |
| Net Cash Flow From Operating Activities, Continuing | -$33.84M |
| Net Cash Flow From Investing Activities | $14.91M |
| Net Cash Flow From Investing Activities, Continuing | $14.91M |
| Net Cash Flow From Financing Activities | $15.71M |
| Net Cash Flow From Financing Activities, Continuing | $15.71M |
| Net Cash Flow | -$3.22M |
| Net Cash Flow, Continuing | -$3.22M |
| Comprehensive Income/Loss | -$47.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$47.88M |
| Other Comprehensive Income/Loss | -$47.88M |